Ticker Details
Apogee Therapeutics, Inc.
IPO Date:	July 14, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.12B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.19 | 2.68%
Avg Daily Range (30 D):	$1.39 | 1.63%
Avg Daily Range (90 D):	$1.70 | 2.25%

Institutional Daily Volume
Avg Daily Volume:	.5M
Avg Daily Volume (30 D):	.47M
Avg Daily Volume (90 D):	.74M

Trade Size
Avg Trade Size (Sh.):	55
Avg Trade Size (Sh.) (30 D):	45
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	1,725
Avg Institutional Trade:	$3.17M
Avg Institutional Trade (30 D):	$4.89M
Avg Institutional Trade (90 D):	$4.24M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$5.08M
Avg Closing Trade (30 D):	$7.49M
Avg Closing Trade (90 D):	$8.65M
Avg Closing Volume:	98.27K

News

Mar 26, 2026 @ 3:33 PM Apogee CEO Sells 20,000 Shares as Stock Surges Nea... Source: Jonathan Ponciano

Mar 25, 2026 @ 1:53 AM Apogee Therapeutics, Inc. Announces Pricing of $35... Source: Na

Mar 22, 2026 @ 11:51 PM Apogee Therapeutics to Host Conference Call to Rep... Source: Na

Feb 25, 2026 @ 8:06 PM Apogee Therapeutics Stock Up 100% as Fund Lifts St... Source: Jonathan Ponciano

Jan 6, 2026 @ 11:00 AM Apogee Therapeutics Announces Positive Interim Res... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-4.33	$-1.06	$-1.03
Diluted EPS	$-4.33	$-1.06	$-1.03
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-274.62M	$-74.11M	$-69.39M
Operating Income / Loss	$-305.27M	$-82.77M	$-78.06M
Cost of Revenue
Net Cash Flow	$344.59M	$320.25M	$23.64M
PE Ratio

Splits
Jan 08, 2008	1:50